Mead Johnson Nutrition Co. (NYSE:MJN)’s share price dropped 2.5% on Thursday . The stock traded as low as $82.73 and last traded at $82.98, with a volume of 864,795 shares changing hands. The stock had previously closed at $85.07.

A number of research firms have recently commented on MJN. Citigroup Inc. raised their price target on Mead Johnson Nutrition from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $96.00 price target on shares of Mead Johnson Nutrition in a research report on Thursday, June 30th. Societe Generale lowered Mead Johnson Nutrition from a “buy” rating to a “hold” rating and dropped their price target for the stock from $100.00 to $95.00 in a research report on Friday, July 29th. Susquehanna reaffirmed a “hold” rating on shares of Mead Johnson Nutrition in a research report on Thursday, June 16th. Finally, Zacks Investment Research lowered Mead Johnson Nutrition from a “buy” rating to a “hold” rating in a research report on Monday, June 13th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $96.00.

The company has a market capitalization of $15.55 billion and a PE ratio of 31.68. The firm’s 50-day moving average price is $87.91 and its 200-day moving average price is $84.20.

Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.10. The company earned $941.50 million during the quarter, compared to the consensus estimate of $967.25 million. The company’s quarterly revenue was down 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.76 EPS. Analysts predict that Mead Johnson Nutrition Co. will post $3.52 EPS for the current year.

In other news, SVP Graciela Monteagudo sold 45,873 shares of the business’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the transaction, the senior vice president now directly owns 13,800 shares of the company’s stock, valued at approximately $1,209,432. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kimberly A. Casiano sold 710 shares of the business’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the transaction, the director now directly owns 7,110 shares in the company, valued at $638,122.50. The disclosure for this sale can be found here.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.